Current Neuro-Oncology
Volume
26 Number 19
10 September 2024
Home > Publications > Current Neuro-Oncology > Volume 26, Year 2024 > Number 19, 10 September
Hiong A, Lapidus AH, Gately L, Sinclair G, Ameratunga M.
Herpes
zoster in patients with glioma treated with temozolomide.
J
Clin Neurosci. 2024 Sep 1;129:110816. doi:
10.1016/j.jocn.2024.110816? PMID:
39222582. Observational study˰
ˍ
Simoneau J, Robertson P, Muraszko K, Maher CO, Garton H, Calvert
R, Koschmann C, Upadhyaya SA, Mody R, Brown N, Kumar-Sinha C,
Parmar H, Camelo-Piragua S, Franson AT.
Long-Term
Tumor Stability After First-Line Treatment With Larotrectinib in
an Infant With NTRK2 Fusion-Positive High-Grade Glioma.
J
Natl Compr Canc Netw. 2024 Sep;22(7):e247045. doi:
10.6004/jnccn.2024.7045. PMID:
39236755. Case report. ˍ
Li F, Wang D, Wang N, Wu L, Yu B.
A
nomogram with Ki-67 in the prediction of postoperative recurrence
and death for glioma.
Sci
Rep. 2024 Sep 2;14(1):20334. doi:
10.1038/s41598-024-71275-9. PMID:
39223159. Observational study. ˍ
Zhong W, Mao J, Wu D, Peng J, Ye W.
The
efficacy of stereotactic radiotherapy followed by bevacizumab and
temozolomide in the treatment of recurrent glioblastoma: a case
report.
Front
Pharmacol. 2024 Sep 4;15:1401000. doi:
10.3389/fphar.2024.1401000. PMID:
39295944. Case report. ˍ
**Löding S, Antti H, Sjöberg RL, Melin B, Björkblom
B.
Blood
based metabolic markers of glioma from pre-diagnosis to surgery.
Sci
Rep. 2024 Sep 5;14(1):20680. doi:
10.1038/s41598-024-71375-6. PMID:
39237693. Observational study. ˍ
**Alyasova AV, Ben Ammar AM, Zarkua VT, Rerberg AG.
A
case report of successful combined intra-arterial immunotherapy
and cytokine genetic therapy treatment in a patient with recurrent
glioblastoma.
Chin
Clin Oncol. 2024 Sep 6:cco-24-34. doi:
10.21037/cco-24-34. PMID:
39260431. Case report. ˍ
Lenga P, Kühlwein D, Grutza M, Issa M, Hinz F, Sahm F, Selt
F, Milde T, Günther P, Unterberg AW, Krieg SM, Damaty AE.
Decoding
pediatric spinal tumors: a single-center retrospective case series
on etiology, presentation, therapeutic strategies, and outcomes.
Neurosurg
Rev. 2024 Sep 6;47(1):557. doi:
10.1007/s10143-024-02770-w. PMID:
39240372. Observational study. ˍ
Reinders AN, Koshy M, Korpics M.
The
Patterns of Failure and Prognostic Impact of Tumor Location in
Patients Undergoing Reirradiation for Glioblastoma.
Cureus.
2024 Sep 6;16(9):e68820. doi:
10.7759/cureus.68820. PMID:
39371788. Observational study. ˍ
Soleimani Z, Saboori M, Abedi I, Irannejad M, Khanbabapour S.
Diffusion-weighted
MR image analysis based on gamma distribution model for
differentiating benign and malignant brain tumors.
Medicine
(Baltimore). 2024 Sep 6;103(36):e39593. doi:
10.1097/MD.0000000000039593? PMID:
39252229. Observational study. ˍ
Zhang C, Wang J, Niu Z, Zhang K, Wang C, Wang S, Hou S, Yu D, Lin
N.
Identification
of a nomogram predicting overall survival based on ADAP2-related
apoptosis genes in gliomas.
Int
Immunopharmacol. 2024 Sep 6;142(Pt A):113084. doi:
10.1016/j.intimp.2024.113084. PMID:
39243555. Observational study˰
ˍ
Li R, Zhang Z, Zhang X, Song J, Wu Y, Wu L, Mao S, Jiang J, Zeng
L.
Optimizing
post-craniotomy recovery: insights from symptom network analysis
in primary brain tumor patients.
Neurosurg
Rev. 2024 Sep 7;47(1):565. doi:
10.1007/s10143-024-02804-3. PMID:
39242405. Observational study˰
ˍ
Basaran AE, Arlt F, Güresir E, Vychopen M, Wach J.
Sexual
dysfunction after surgery for primary sporadic cranial
meningiomas: prevalence and risk factors.
J
Neurooncol. 2024 Sep 10. doi:
10.1007/s11060-024-04817-w. PMID:
39254812. Observational study.
ˍ
Gerritsen JKW, Young JS, Krieg SM, Jungk C, Ille S, Schucht P,
Nahed BV, Broekman MLD, Berger M, De Vleeschouwer S, Vincent AJPE.
Resection versus biopsy in patients
with glioblastoma (RESBIOP study): study protocol for an
international multicentre prospective cohort study (ENCRAM 2202).
BMJ
Open. 2024 Sep 10;14(9):e081689. doi:
10.1136/bmjopen-2023-081689. PMID:
39260848. Interventional study protocol. ˍ
Isikay AI, Gurses ME, Gecici NN, Baylarov B, Cekic E, Narin F,
Karakaya D, Hanalioglu S, Bilginer B.
Congenital
Brain Tumors: Surgical Outcomes and Long-Term Prognostic Factors.
World
Neurosurg. 2024 Sep 10:S1878-8750(24)01559-6. doi:
10.1016/j.wneu.2024.09.021. PMID:
39265942. Observational study˰
ˍ
Stegat L, Eckhardt A, Gocke A, Neyazi S, Pohl L, Schmid S,
Dottermusch M, Frank S, Pinnschmidt H, Herms J, Glatzel M, Snuderl
M, Schweizer L, Thomas C, Neumann J, Dorostkar MM, Schüller
U, Wefers AK.
Integrated analyses
reveal two molecularly and clinically distinct subtypes of H3
K27M-mutant diffuse midline gliomas with prognostic significance.
Acta
Neuropathol. 2024 Sep 10;148(1):40. doi:
10.1007/s00401-024-02800-3. PMID:
39256213. Laboratory investigation. ˍ
Wang YC, Wu KL, Jung SM, Wu CT.
Metastasis
of World Health Organization Grade II and Grade III Meningiomas:
Long-Term Survival and Associated Factor Analysis.
World
Neurosurg. 2024 Sep 10:S1878-8750(24)01555-9. doi:
10.1016/j.wneu.2024.09.013. PMID:
39265944. Observational study˰
ˍ